-
Portland immunotherapy startup tops $10M in funding as it launches first clinical trial
firstwordpharma
May 30, 2018
Emmanuel Akporiaye, founder of Veana Therapeutics, said the start-up raised its first venture funding, a $542 000 seed round that brings its total funding to more than $10 million, reported GeekWire
-
Acute Pain - 2018 Pipeline Highlights
biospace
April 20, 2018
Acute Pain Pipeline Highlights - 2018, provides the most up-to-date information on key pipeline products in the global Acute Pain market.
-
Feinstein, NIH launch groundbreaking clinical trial for new lupus medication
biospectrumasia
April 08, 2018
Trial examines use of synthetic endocannabinoid mimetic with no psychotropic properties to treat lupus inflammation
-
MYR Pharma Completes Clinical Trial of Myrcludex B in Chronic Hepatitis Delta
biospace
March 13, 2018
MYR Pharma GmbH today announced the completion of its MYR 202 clinical trial
-
Caligor Holdco, LLC, Leader in Strategic Clinical Trial Services, Acquires The Coghlan Group
prnasia
November 17, 2017
Caligor Holdco, LLC., announced today the acquisition of The Coghlan Group, a leading materials management service company for clinical trials.
-
First made-in-India ‘digital pill’ to undergo clinical trial for diabetes
expressbpd
November 16, 2017
The #WeDiDiT (Wellthy Digital Diabetes Therapy) trial is all set to prove the efficacy of its 16-week structured diabetes management programme delivered through a mobile app.
-
MD Anderson, Daiichi Sankyo collaborate to accelerate development of acute myeloid leukemia therapie
pharmaasia
September 18, 2017
The collaboration will launch multiple phase 1 and 2 clinical trials conducted by MD Anderson with the aim of expediting delivery of new therapies.
-
Clinical trial matching platform raises $11M backed by Merck’s tech fund
fiercebiotech
September 14, 2017
Antidote, as one of them, just recently raised $11 million in a financing round led by Merck Global Health Innovation (GHI) Fund.
-
Bioverativ taps patient social network for input on hemophilia trial design
fiercepharma
August 25, 2017
Bioverativ designed a hemophilia drug trial to address newly unearthed unmet needs, by gauging pain in addition to bleeding.
-
Lilly-backed Cavion poaches Teva executive as R&D head
fiercebiotech
August 16, 2017
Cavion got off a $26.1 million series A financing this year with Lilly Ventures, Novartis Venture Fund and Enso Ventures.